We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > VITT

News List

Possible identification of blood clot trigger for AstraZeneca COVID-19 vaccine PharmaTimes
December 03, 2021
Researchers have identified in those patients experiencing blood clots after vaccination a subsequent condition referred to as vaccine-induced immune thrombotic thrombocytopenia (VITT).
NICE publishes ‘rapid’ guideline on rare blood clots associated with COVID-19 jab pharmatimes
August 02, 2021
The UK’s National Institute for Health and Care Excellence (NICE) has published a new guideline of the rare syndrome vaccine-induced immune thrombocytopenia and thrombosis (VITT) associated with COVID-19 vaccination.
NICE to develop guideline for rare blood clots associated with COVID-19 vaccination pharmatimes
July 15, 2021
The National Institute for Health and Care Excellence (NICE) will develop a guideline on the management and treatment of rare blood clots and low platelet counts associated with COVID-19 vaccination.
New treatment demonstrated for people with vaccine clots firstwordpharma
June 10, 2021
A new lifesaving treatment for people suffering from vaccine-related blood clots has been demonstrated by scientists at McMaster University.